| Psychosocial interventions for people with both severe mental illness and substance misuse GE Hunt, N Siegfried, K Morley, C Brooke‐Sumner, M Cleary Cochrane Database of Systematic Reviews, 2019 | 417* | 2019 |
| Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi‐centre, randomized, double‐blind, placebo‐controlled trial KC Morley, M Teesson, SC Reid, C Sannibale, C Thomson, N Phung, ... Addiction 101 (10), 1451-1462, 2006 | 207 | 2006 |
| Increased anxiety and impaired memory in rats 3 months after administration of 3, 4-methylenedioxymethamphetamine (“ecstasy”) KC Morley, JE Gallate, GE Hunt, PE Mallet, IS McGregor European journal of pharmacology 433 (1), 91-99, 2001 | 165 | 2001 |
| (±)-3, 4-Methylenedioxymethamphetamine (MDMA,‘Ecstasy’) increases social interaction in rats KC Morley, IS McGregor European journal of pharmacology 408 (1), 41-49, 2000 | 130 | 2000 |
| Increased anxiety in rats after 3, 4-methylenedioxymethamphetamine: association with serotonin depletion CG Gurtman, KC Morley, KM Li, GE Hunt, IS McGregor European journal of pharmacology 446 (1-3), 89-96, 2002 | 129 | 2002 |
| Baclofen for the treatment of alcohol use disorder: the Cagliari Statement R Agabio, JMA Sinclair, G Addolorato, HJ Aubin, EM Beraha, F Caputo, ... The Lancet Psychiatry 5 (12), 957-960, 2018 | 128 | 2018 |
| Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: a systematic review and meta-analysis M Pierce, A Sutterland, EM Beraha, K Morley, W van den Brink European Neuropsychopharmacology 28 (7), 795-806, 2018 | 126 | 2018 |
| Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial KC Morley, A Baillie, I Fraser, A Furneaux-Bate, G Dore, M Roberts, ... The British Journal of Psychiatry 212 (6), 362-369, 2018 | 117 | 2018 |
| Baclofen for the treatment of alcohol dependence and possible role of comorbid anxiety KC Morley, A Baillie, S Leung, G Addolorato, L Leggio, PS Haber Alcohol and alcoholism 49 (6), 654-660, 2014 | 116 | 2014 |
| Increased anxiety and" depressive" symptoms months after MDMA (" ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes IS McGregor, CG Gurtman, KC Morley, KJ Clemens, A Blokland, KM Li, ... Psychopharmacology 168, 465-474, 2003 | 112 | 2003 |
| Pharmacotherapeutic agents in the treatment of methamphetamine dependence KC Morley, JL Cornish, A Faingold, K Wood, PS Haber Expert opinion on investigational drugs 26 (5), 563-578, 2017 | 101 | 2017 |
| Serotonin (1A) receptor involvement in acute 3, 4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat KC Morley, JC Arnold, IS McGregor Progress in Neuro-Psychopharmacology and Biological Psychiatry 29 (5), 648-657, 2005 | 99 | 2005 |
| Heat increases 3, 4-methylenedioxymethamphetamine self-administration and social effects in rats JL Cornish, Z Shahnawaz, MR Thompson, S Wong, KC Morley, GE Hunt, ... European journal of pharmacology 482 (1-3), 339-341, 2003 | 91 | 2003 |
| The use of baclofen as a treatment for alcohol use disorder: a clinical practice perspective R De Beaurepaire, JMA Sinclair, M Heydtmann, G Addolorato, HJ Aubin, ... Frontiers in psychiatry 9, 708, 2019 | 88 | 2019 |
| Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol? K Richardson, A Baillie, S Reid, K Morley, M Teesson, C Sannibale, ... Addiction 103 (6), 953-959, 2008 | 88 | 2008 |
| New Australian guidelines for the treatment of alcohol problems: an overview of recommendations PS Haber, BC Riordan, DT Winter, L Barrett, J Saunders, L Hides, M Gullo, ... Medical Journal of Australia 215, S3-S32, 2021 | 87 | 2021 |
| Alcohol use disorder and circulating cytokines: A systematic review and meta-analysis C Adams, JH Conigrave, J Lewohl, P Haber, KC Morley Brain, Behavior, and Immunity 89, 501-512, 2020 | 85 | 2020 |
| The role of clinical champions in facilitating the use of evidence-based practice in drug and alcohol and mental health settings: a systematic review K Wood, V Giannopoulos, E Louie, A Baillie, G Uribe, KS Lee, PS Haber, ... Implementation Research and Practice 1, 2633489520959072, 2020 | 80 | 2020 |
| Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA (“Ecstasy”) in rats KC Morley, KM Li, GE Hunt, PE Mallet, IS McGregor Neuropharmacology 46 (7), 954-965, 2004 | 74 | 2004 |
| Systematic reviews of mindfulness and acceptance and commitment therapy for alcohol use disorder: should we be using third wave therapies? SP Byrne, P Haber, A Baillie, DSJ Costa, V Fogliati, K Morley Alcohol and Alcoholism 54 (2), 159-166, 2019 | 67 | 2019 |